Streptococcus pneumoniae News and Research

RSS

Streptococcus pneumoniae, or Pneumococcus, is a very common bacterial infection in both industrialized and developing countries. In particular, young children and the elderly represent high-risk populations of developing pneumococcal infections. According to the WHO, the bacterium kills up to one million children under the age of five years each year worldwide. It accounts for many Bacterial Meningitis cases in adults and it is the most common cause of Bacteraemia, Pneumonia, Meningitis and Otitis media in young children.

What is the association between air ventilation and pathogen transmission?

Researchers assessed the association between indoor air respiratory pathogens and natural ventilation, carbon dioxide (CO2) levels, and air filtration.

27 Sep 2022

Novel method can be used to study the resistance profile of bacteria that cause meningitis

A study published in the journal PLOS ONE could one day help health workers determine whether bacteria of the species Streptococcus pneumoniae, which cause meningitis – an inflammation of the membranes that envelop the brain and spinal cord – are resistant to antibiotics.

6 Sep 2022

The role of nasal microbiome in Parkinson's disease

A recent study provides an overview of how the nasal bacterial population influences olfactory processing and neurodegeneration.

5 Sep 2022

Study shows how the brain's tool for waste clearance malfunctions during bacterial meningitis

Bacterial meningitis is a life-threatening infectious disease of the brain that leaves many survivors with long-lasting neurological impairments.

29 Aug 2022

What is the prevalence of bacterial co-infections during COVID-19?

Researchers evaluated the characteristics and prevalence of bacterial co-infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

22 Aug 2022

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

A pioneering genomic surveillance study has provided the clearest picture yet of the arms race between Streptococcus pneumoniae, the bacterium responsible for a range of illnesses such as pneumonia and meningitis, and the vaccines designed to protect against the most dominant types. A strain called GPSC10 was found to be a particular threat, due to its increased virulence, ability to transform its structure to evade vaccines and its resistance to several common antibiotics.

17 Aug 2022

How did the COVID-19 pandemic impact the epidemiology of antibiotic resistant bacteria?

In an article, a mathematical model was used to explore how behavioral responses to the COVID-19 pandemic impact the anti-microbial resistance across communities.

11 Aug 2022

Researchers unravel the mechanism of teixobactin at the atomic level

Researchers explored the mechanisms underlying the bactericidal action of teixobactin at an atomic level.

8 Aug 2022

MIT researchers design new sensor to distinguish between viral and bacterial pneumonia

Many different types of bacteria and viruses can cause pneumonia, but there is no easy way to determine which microbe is causing a particular patient's illness.

13 Jun 2022

Scientists identify a new pneumococcal vaccine candidate

Researchers at Karolinska Institutet in Sweden have identified a new vaccine candidate against pneumococci, bacteria that can cause pneumonia, sepsis, and meningitis.

2 Jun 2022

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

Researchers reviewed available mucosal vaccines discussing the current challenges and ways to advance the existing approaches.

25 May 2022

Repurposed drug clofoctol blocks SARS-CoV-2 replication in mouse study

A new paper presents the results of a mouse study using the repurposed antibacterial drug clofoctol against this virus.

23 May 2022

Research reveals how a leaky gut leads to inflammation in the lungs

Why are older adults more likely to get seriously ill or even die from pneumonia? It turns out the cause may have as much to do with the gut as it does with the lungs.

11 May 2022

Nurseries, schools, nursing homes and other indoor settings exposed to high levels of respiratory pathogens during winter

High levels of respiratory pathogens are present in the air of nurseries, schools, nursing homes and other indoor settings during winter, according to new research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal, (23-26 April).

23 Apr 2022

Streptococcus pneumoniae News and Research

Further Reading

What is the association between air ventilation and pathogen transmission?

Novel method can be used to study the resistance profile of bacteria that cause meningitis

The role of nasal microbiome in Parkinson's disease

Study shows how the brain's tool for waste clearance malfunctions during bacterial meningitis

What is the prevalence of bacterial co-infections during COVID-19?

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

How did the COVID-19 pandemic impact the epidemiology of antibiotic resistant bacteria?

Researchers unravel the mechanism of teixobactin at the atomic level

MIT researchers design new sensor to distinguish between viral and bacterial pneumonia

Scientists identify a new pneumococcal vaccine candidate

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

Repurposed drug clofoctol blocks SARS-CoV-2 replication in mouse study

Research reveals how a leaky gut leads to inflammation in the lungs

Nurseries, schools, nursing homes and other indoor settings exposed to high levels of respiratory pathogens during winter

Pathogens in pneumonia-associated respiratory samples from Wuhan prior to SARS-CoV-2 emergence

Antimicrobial resistance causes more deaths than HIV and malaria

The effect of COVID-19 on routine immunizations for vaccine-preventable diseases

Importance of pneumococcal vaccination during the COVID-19 pandemic

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News